Latest News

National Academy of Medicine Proposes AI Code of Conduct for Healthcare Transformation
The National Academy of Medicine (NAM) has released a comprehensive landscape review and a draft framework aimed at fostering accurate, safe, reliable, and ethical integration of artificial intelligence (AI) in healthcare and biomedical science. The initiative underscores the potential of AI to transform healthcare positively while emphasizing the importance of responsible behavior in its development, use, and ongoing assessment. Derived from the Leadership Consortium’s Learning Health System Core Principles, an ongoing initiative since 2006, the NAM's draft framework promotes inclusive collaboration, ongoing safety assessment, efficiency, and environmental protection as core tenets. These principles are designed to guide and assess behavior in AI implementation within the complex

AdventHealth Celebration Performs World's First Kidney Histotripsy
A recent groundbreaking development in the field of urology has brought new hope to patients with kidney tumors. AdventHealth Celebration has introduced a pioneering procedure utilizing histotripsy, a non-invasive technique employing sound waves to eradicate tumors. Spearheaded by Dr. Michael McDonald, a distinguished

EMA approves Mitochon’s neurogenerative disease study
A beacon of hope has emerged for patients battling several neurodegenerative diseases! The European Medicines Agency (EMA) has greenlit a Phase I/IIa pilot study led by Mitochon Pharmaceuticals to investigate MP101, a revolutionary oral drug targeting the very core of cell energy: mitochondria. This is a crucial step
Articles

New Therapeutic Device Offers Hope in the Fight Against Pediatric Sepsis
In the ongoing battle against sepsis, a life-threatening condition triggered by a dysregulated response to infection, a breakthrough therapeutic device has emerged to offer a ray of hope, particularly for pediatric patients. Developed at the University of Michigan in collaboration with SeaStar Medical, the selective cytopheretic device (SCD), commercially known as Quelimmune, has recently received FDA approval for use in children with acute kidney injury and sepsis or septic conditions necessitating continuous kidney replacement therapy in the ICU. Sepsis, often referred to as "blood poisoning," arises from various infectious agents, setting off a chain reaction within the body's immune system. The condition's severity stems not from the pathogens themselves but from the hyperactive
Specialities

Tailored Physical Therapy Program Shows Significant Improvements in Axial Spondyloarthritis Patients
A recent study published in the journal Therapeutic Advances in Musculoskeletal Disease has demonstrated the efficacy of a two-week tailored physical therapy program in significantly improving spinal mobility and function among individuals with axial spondyloarthritis (axSpA). Led by a research team at Ruhr-University Bochum in Germany, the study utilized a novel electronic device called Epionics SPINE (ES) to objectively evaluate spinal mobility, providing valuable clinical evidence for the effectiveness of exercise-based interventions in managing axSpA. Axial spondyloarthritis is a chronic arthritis primarily affecting the joints in the spine, pelvis, and chest. It encompasses both nonradiographic axSpA (nr-axSpA), where no visible damage is observed on X-rays, and radiographic axSpA

Revolutionizing Stroke Rehabilitation: The Promise of Telerehabilitation
In the aftermath of a stroke, individuals often confront formidable challenges, particularly in the restoration of lower body mobility and the pursuit of regained independence. These obstacles not only encompass physical limitations but also extend to mental well-being and overall quality of life. Recognizing this
Medical Equipment

HORIBA Medical Launches Next Neneration HELO Fully Automated Modular Hematology Solution
Montpellier, France (4 January 2024) – HORIBA Medical has launched the new HELO 2.0 high throughput automated hematology platform which is CE-IVDR approved. Following the success of HORIBA Medical’s previous HELO, this new generation high-end hematology range has been designed in consultation with customers to further improve and cover all needs of high throughput fully automated hematology. HELO 2.0 offers a highly flexible and efficient modular hematology solution that is fully scalable with many possible configurations for mid to large-scale laboratories. HORIBA Medical’s advanced technologies embedded in the platform’s Yumizen H2500 and Yumizen H1500 hematology analyzers ensure high quality analytical performance. This includes 360-degree sample mixing without any premixing required.

Pulmonary embolism startup Flow Medical raises $2M in friends-and-family round
Flow Medical has recently secured $2 million in a funding round primarily from friends and family. The Chicago-based company is actively engaged in the development of an innovative thrombolysis catheter designed to address acute pulmonary embolism (PE). The secured funds will be directed towards research and

Olympus Announces Launch of Next Generation Electrosurgical Generator
Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced market availability of its newest electrosurgical generator for use in the treatment of bladder cancer and enlarged prostate. The ESG-410 Electrosurgical Generator supports options
Product Focus

FDA clears next-generation cardiovascular, thoracic CT scanners
Arineta Cardio Imaging has recently announced a significant milestone with the FDA 510(k) clearance and the subsequent launch of its advanced cardiovascular CT scanners. The cutting-edge system, named SpotLight, has been meticulously crafted to cater specifically to cardiovascular CT imaging needs. What sets this technology apart is its ability to provide a broad 25 cm field of view, boasting an impressive 120 msec temporal resolution, one-beat whole heart coverage, and spatial resolution featuring a 0.5 mm detector. Additionally, the system incorporates a powerful 139kW effective X-ray tube, contributing to its high-performance capabilities. In a press release, Arineta Cardio Imaging revealed that the next-generation product, SpotLight Duo, expands the system's capabilities further by

Laser-assisted robotic knee surgery advances orthopaedic treatment
Robotic-assisted knee replacement surgery with laser technology is garnering attention as a groundbreaking advancement in orthopaedic care. With its array of benefits for patients and surgeons alike, this cutting-edge approach is transforming the landscape of knee surgeries. In an interview, Dr. Anush Rao, Specialist
Pharmaceuticals

TL1A Protein Causes a Significant Shift in Immunology
Revolutionizing IBD Treatment: The Rise of TL1A Drugs In the landscape of inflammatory bowel disease (IBD) treatment, a seismic shift is underway as pharmaceutical giants invest billions into developing drugs targeting TL1A, a protein found in elevated levels in IBD patients. Recent acquisitions and partnerships, such as Merck's $10.8 billion acquisition of Prometheus Biosciences and Sanofi's $1.5 billion partnership with Teva, underscore the intense competition and high stakes involved in this burgeoning field. TL1A: A Promising Target for IBD and Beyond TL1A has emerged as a promising target for new drugs, with the potential to impact not only ulcerative colitis and Crohn's disease but also a spectrum of other inflammatory conditions including arthritis, skin diseases, and lung diseases.
Campaigns & Recent Studies

Recent Study Highlights Progress in Breast Cancer Prevention
In the realm of breast cancer prevention, the exploration of dietary interventions and their interaction with the gut microbiome has unveiled promising avenues for reducing disease risk. Recent research, including a study published in Microbiology Spectrum, sheds light on the potential of flaxseed—a humble yet potent dietary component—in this endeavor. Integrating new insights, particularly regarding the role of lignan and its interaction with gut bacteria, enriches our understanding of how flaxseed may serve as a shield against breast cancer. Unveiling Lignan's Role: The Gut Microbiome Connection At the heart of flaxseed's potential lies lignan, a compound whose beneficial effects are unlocked through metabolism by the gut microbiota. Once metabolized, lignan releases bioactive

Study Identifies Important Factors for Nanoparticle Transport in Tumors
The field of drug delivery has witnessed significant advancements with the emergence of nanoparticles as carriers for therapeutic agents. However, utilizing nanoparticles for drug delivery comes with its own set of challenges, particularly in the complex context of the tumor microenvironment. A recent study published
Diet & Nutrition

Food SENSE offers new ways of assessing and tackling malnutrition in Uganda.
CGIAR’s Sustainable Animal Productivity and Livelihoods, Nutrition and Gender inclusion Initiative (SAPLING) has developed a tool for assessing, identifying and responding to food and nutrition security problems in developing countries. The Food Security, Environments and Nutrition: Structured Evidence (FoodSENSE), is a decision support process developed by SAPLING researchers to aid decision makers in identifying barriers to improved food security and nutrition, and then to structure dialogue for prioritization of appropriate solutions for target demographic groups. The tool provides site-specific information on foods consumed, where they are sourced and the nutritional outcomes. It is also used to evaluate food systems and environments, including markets, value chains and socio-cultural

What Are The Signs That Iron Pills Are Working?
The signs that iron pills are working vary from person to person. Some people may notice an improvement in energy and other anemia symptoms. People without noticeable anemia symptoms may see little change. People often begin responding to iron pills within 2 weeks. A doctor can monitor if supplementation is working by

The “Medical Bypass”: New Drugs to Strike Obesity
The FDA has granted Mounjaro, drug that showed comparable potential to gastric bypass surgery, a Fast Track designation to treat obesity. In what’s being called a “medical bypass”, new anti-obesity drugs are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries. In
Country Reports

Egyptian President El-Sisi Pushes for Private Sector Engagement in Health Sector
In a recent meeting, President El-Sisi of Egypt emphasized the government's commitment to bolstering the private sector's involvement in the health sector and attracting more investment into this critical domain. Prime Minister Mostafa Madbouly and Minister of Health and Population Khaled Abdel-Ghaffar joined the president in discussing the progress and future prospects of various national health projects. According to a statement released by the presidential office, the meeting delved into the advancements of key health initiatives, including the inauguration of the French Gustave Roussy Institute's branch in Egypt, established in collaboration with El-Salam Hospital. Additionally, plans for the development of a medical city at the Nasser Institute (Nile Medical City) were reviewed,

Philippines' to introduce Pharmaceutical Ecozones Backed by PEZA
The Philippines faces significant challenges concerning access to affordable medicines, prompting President Marcos Jr. to introduce a strategic initiative aimed at revolutionizing the pharmaceutical landscape through the establishment of Pharmaceutical Ecozones (PEZs). With a comprehensive set of goals, involving
Events

Arab Health anticipates 3,000 companies from 70 countries for its next edition in January
The 2023 edition of Arab Health will return to the Dubai World Trade Centre from 30th January – 2nd February under the show's theme, 'Innovation and Sustainability in Healthcare', the organizers said. Exhibitor companies are also anticipated to rise, increasing from 2,828 to over 3,000 from 70 countries, according to Informa Markets. Arab Health has underscored its position as the epicenter of healthcare trade and reaffirmed its support for global businesses and governments by securing AED2.8 billion worth of healthcare industry-related contracts, according to a GRS Explore Exhibitor Survey during the 2022 edition, which was held in Dubai in January. The exhibition plays an integral role in supporting UAE Government initiatives such as ‘Make it in the Emirates’, a platform for developing

COMING EVENTS

India

InnoHEALTH 2023


December
15
India

Medical Expo Lucknow 2023


December
22
South Africa

International Conference on Medical & Health Science 2023


December
25
United States of America

Practical AI for Drug Discovery & Preclinical Development Summit 2024


January
30
United States of America

Mayo Clinic Wound Symposium 2024


February
28
United Kingdom

Biomarkers UK 2024


February
29

OTHER CPH INDUSTRY WEBSITES